How to buy Genfit stock (GNFT)

Genfit is a biotechnology business based in the US. Genfit shares (GNFT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.80 – a decrease of 0.52% over the previous week. Genfit employs 169 staff and has a trailing 12-month revenue of around $80.5 million.

Our top picks for where to buy Genfit stock

Buy Genfit stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Genfit stock price (NASDAQ: GNFT)

Use our graph to track the performance of GNFT stocks over time.

Genfit shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$3.80
52-week range	$3.31 - $6.42
50-day moving average more info button	$4.97
200-day moving average more info button	$4.36
Wall St. target price	$10.10
PE ratio more info button	9.7179
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.39

Is it a good time to buy Genfit stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genfit price performance over time

Historical closes compared with the close of $3.8 from 2024-12-20

1 week (2024-12-13)	-0.52%
1 month (2024-11-22)	-9.52%
3 months (2024-09-20)	-21.49%
6 months (2024-06-21)	-2.06%

1 year (2023-12-22)	0.53%
2 years (2022-12-22)	2.15%
3 years (2021-12-22)	5.63
5 years (2019-12-20)	18

Is Genfit stock undervalued or overvalued?

Valuing Genfit stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genfit's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Genfit's P/E ratio

Genfit's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Genfit shares trade at around 10x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Genfit's EBITDA

Genfit's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $21.9 million.

The EBITDA is a measure of a Genfit's overall financial performance and is widely used to measure a its profitability.

Genfit financials

Revenue TTM	$80.5 million
Operating margin TTM	51%
Gross profit TTM	$26.2 million
Return on assets TTM	6.51%
Return on equity TTM	25.91%
Profit margin	27.68%
Book value	$1.96
Market Capitalization more info button	$189.1 million

TTM: trailing 12 months

Genfit share dividends

We're not expecting Genfit to pay a dividend over the next 12 months.

Genfit share price volatility

Over the last 12 months, Genfit's shares have ranged in value from as little as $3.31 up to $6.4229. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genfit's is 1.122. This would suggest that Genfit's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Genfit overview

Genfit S. A. , a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2a trial to treat patients with cholangiocarcinoma (CCA); VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia; CML-022; SRT-015, an ASK1 inhibitor targets the inhibition of cellular apoptosis, inflammation, and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.

Frequently asked questions

null
What percentage of Genfit is owned by institutions?
Currently 0.261% of Genfit shares are held by institutions. How many people work for Genfit?
Latest data suggests 169 work at Genfit. When does the fiscal year end for Genfit?
Genfit's fiscal year ends in December. Where is Genfit based?
Genfit's address is: Parc EurasantE, Loos, France, 59120 What is Genfit's ISIN number?
Genfit's international securities identification number is: US3722791098 What is Genfit's CUSIP number?
Genfit's Committee on Uniform Securities Identification Procedures number is: 372279109